The global single-use bioprocessing market reached a value of USD 20,960 million in 2022 and is projected to be worth around USD 84,140 million by 2032, experiencing a compound annual growth rate (CAGR) of 15.46% from 2023 to 2032.
The global single-use bioprocessing market reached a value of USD 20,960 million in 2022 and is projected to be worth around USD 84,140 million by 2032, experiencing a compound annual growth rate (CAGR) of 15.46% from 2023 to 2032.
As indicated by research conducted by Towards Healthcare, the global single-use bioprocessing market is set to expand significantly. starting from USD 23,080 million in 2023. Single-use bioprocessing refers to a technology and approach used in the biopharmaceutical industry where disposable and pre-sterilized components are used for various stages of bioprocessing, including cell culture, fermentation, purification, and storage. This eliminates the need for traditional stainless-steel equipment and complex cleaning and sterilization processes, offering several advantages such as reduced cross-contamination risk, faster turnaround times, increased flexibility, and decreased capital investment. Single-use bioprocessing has gained popularity due to its potential to improve operational efficiency and reduce the risk of batch failures, making it a key trend in modern biopharmaceutical manufacturing.
Request a short version of this report @ https://www.towardshealthcare.com/personalized-scope/5030
Cost Efficiency Foster the Single-Use Bioprocessing Market
One of the driving factors propelling the rapid growth of the Single-Use Bioprocessing Market is the prominent emphasis on cost efficiency. The adoption of single-use bioprocessing technologies offers several key benefits that contribute to enhanced cost efficiency for biopharmaceutical manufacturers. One of the most significant advantages is the reduction in capital expenditure. Traditional stainless-steel equipment requires a substantial investment for installation and maintenance. In contrast, single-use systems significantly reduce the initial capital outlay, making them an appealing option for companies of all sizes, from established industry players to emerging startups
Parenteral Drug Association has given a cost comparison of the fermentation expansion project, as mentioned in the table below:
| Item | Stainless Steel | Single-Use | Savings |
| Mechanical Equipment | 23.4% | 18.1% | 23% |
| Instrumentation and Control | 21.8% | 17.1% | 22% |
| Manufacturing and Installation | 27.9% | 21.9% | 22% |
| Engineering and Qualification | 26.5% | 22.1% | 17% |
| Transportation | 0.4% | 0.3% | 21% |
| Total | 100.0% | 79.5% | 21% |
In addition, single-use systems contribute to lower labor costs. Traditional bioprocessing setups require skilled operators to manage complex equipment and perform tasks such as cleaning, sterilization, and maintenance. Single-use systems streamline these processes, requiring less specialized labor and enabling companies to optimize their workforce allocation. Furthermore, the reduced facility footprint associated with single-use systems contributes to cost savings. Traditional facilities housing stainless-steel equipment demand more space due to the size and infrastructure requirements.
Thus, the emphasis on cost efficiency has been a pivotal driving factor in the Single-Use Bioprocessing Market. The adoption of single-use bioprocessing technologies addresses various cost-related challenges associated with traditional methods. By reducing capital expenditures, labor costs, energy consumption, and waste generation, single-use systems offer a compelling value proposition to biopharmaceutical and biologics manufacturers. This shift not only drives cost savings but also enhances operational efficiency, accelerates time-to-market, and ultimately contributes to the continued growth of the market.
Energy Consumption: Multi-Use Stainless-Steel Systems vs. Single-Use Systems Reboard Containers and Packaging
The energy usage of stainless-steel systems and single-use systems can exhibit notable variations. The cleansing and sterilization requirements between batches, as well as the maintenance of temperature control during production, contribute to higher energy consumption in stainless steel systems. The elevated energy demand linked to stainless steel systems is a consequence of the necessity for steam and hot water, integral for the cleaning and sterilization processes. Conversely, single-use systems entail less energy compared to stainless steel systems due to their exemption from batch-to-batch cleaning and sterilization. These systems are engineered for one-time use, obviating the need for cleansing and sterilization, which considerably curtails energy usage. Additionally, the lightweight materials used in single-use systems can further diminish energy expenditure during transport and handling.
The energy consumption of bioprocessing systems is also influenced by the warming and cooling of media. Single-use systems can also offer benefits in this domain, as they incorporate a higher surface area-to-volume ratio in their design, enhancing heat transfer rates and subsequently reducing energy consumption
Customize this study as per your requirement @ https://www.towardshealthcare.com/customization/5030
Environmental Sustainability Concern Restraints the market growth
Environmental sustainability concerns act as a significant restraint on the growth of the single-use bioprocessing market. As the global awareness of environmental issues increases, industries are under pressure to adopt practices that are more environmentally friendly and sustainable. Single-use bioprocessing systems, although advantageous in terms of cost and convenience, often involve the use of plastics and other non-biodegradable materials. This raises concerns about the environmental impact of the increased waste generated by single-use systems after they are discarded. The accumulation of plastic waste can contribute to pollution, harm to ecosystems, and long-term environmental degradation. As a result, regulatory bodies and consumers are placing more emphasis on sustainable practices and environmentally responsible solutions.
To address this restraint, companies operating in the single-use bioprocessing market need to invest in research and development to create more eco-friendly and biodegradable materials for single-use systems. Additionally, implementing effective recycling and waste management strategies for single-use components can help mitigate the environmental impact and align with sustainability goals.
Thus, the environmental sustainability concern represents a restraint for the single-use bioprocessing market, necessitating innovation and responsible waste management strategies to balance the advantages of single-use systems with environmental preservation.
Opportunities in the Development of Custom Fit-for-Purpose Solutions
An emerging opportunity in the single-use bioprocessing market is the development of custom fit-for-purpose solutions. As the demand for biopharmaceuticals and biologics continues to grow, manufacturers are looking for ways to optimize their processes and ensure efficient production. Custom fit-for-purpose solutions offer tailored single-use bioprocessing systems that are specifically designed to meet the unique requirements of each biopharmaceutical manufacturing process. This approach involves collaborating closely with biopharmaceutical companies to understand their specific needs, process parameters, and production goals. Based on this understanding, suppliers of single-use bioprocessing components can design and create customized solutions that integrate seamlessly into the manufacturing process. These solutions can include specialized bags, connectors, tubing, and other components that are optimized for a particular application.
The benefits of custom fit-for-purpose solutions are multi-fold. They can enhance process efficiency by eliminating unnecessary steps and components, thereby reducing the risk of contamination and improving overall yield. They can also streamline regulatory compliance by providing a standardized and validated solution tailored to the specific process requirements. Additionally, custom solutions can lead to cost savings by minimizing waste and optimizing resource utilization.
Browse More Reports of Towards Healthcare:
- Generic Drugs Market
- Biotechnology Market
- CAR T-Cell Therapy Market
- Artificial Intelligence (AI) in Drug Discovery Market
- Artificial Intelligence (AI) In Life Sciences Market
- Generative AI in Healthcare Market
Regional Outlook
The regional outlook for the Single-Use Bioprocessing Market presents a dynamic landscape across North America, Europe, Asia Pacific, and the Latin America, Middle East, and Africa (LAMEA) regions. In North America, the market continues to flourish due to robust investments in biopharmaceutical research and development, coupled with an established regulatory framework that favors the adoption of single-use bioprocessing technologies. Europe, on the other hand, showcases a growing trend towards sustainable and cost-effective manufacturing solutions, driving the uptake of single-use bioprocessing systems among pharmaceutical and biotech companies.
The Asia Pacific region is experiencing rapid growth fueled by the expansion of the biopharmaceutical sector in emerging economies, with a focus on reducing manufacturing costs and enhancing production efficiency. In the LAMEA region, increasing awareness about the benefits of single-use bioprocessing, alongside an evolving healthcare infrastructure, is gradually fostering market growth. Thus, these regions collectively contribute to the evolving global landscape of single-use bioprocessing, with each area presenting unique opportunities and challenges that shape the market’s trajectory.
Recent Developments:
- In April 2023, Merck has introduced its latest product, the Ultimus Single-Use Process Container Film. This innovative film is specifically engineered to offer exceptional strength and leak-proof properties, catering to single-use assemblies utilized in the bioprocessing of liquid applications.
- In August 2022, Thermo Fisher Scientific Inc. inaugurated its most expansive single-use technology production facility in Greater Nashville. The facility, encompassing 400,000 square feet and costing $105 million, positions the company to effectively address the swiftly increasing requirement for bioprocessing materials, essential for manufacturing vaccines and revolutionary treatments for ailments such as cancer.
Major Market Players:
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Lonza
- Pall Corporation
- Corning Incorporated
- Rentschler Biopharma SE
- Eppendorf AG
- Sartorius AG
- General Electric Company (GE Healthcare)
Market Segmentation
By Product
- Filtration Assemblies
- Disposable Bioreactors
- Disposable Mixers
- Media Bags & Containers
- Others
By Application
- Filtration
- Purification
- Cell Culture
- Others
By End User
- Biopharmaceutical Manufacturers
- Clinical & Academic Research Institutes
- Others
By Workflow
- Upstream
- Fermentation
- Downstream
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthacre.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Browse our Brand-New Journal@ https://www.towardspackaging.com
Browse our Consulting Website@ https://www.precedenceresearch.com
For Latest Update Follow Us: